1. Home
  2. AHCO vs PGEN Comparison

AHCO vs PGEN Comparison

Compare AHCO & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AdaptHealth Corp.

AHCO

AdaptHealth Corp.

HOLD

Current Price

$10.84

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.17

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AHCO
PGEN
Founded
2012
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.4B
IPO Year
2017
2013

Fundamental Metrics

Financial Performance
Metric
AHCO
PGEN
Price
$10.84
$4.17
Analyst Decision
Strong Buy
Buy
Analyst Count
4
5
Target Price
$13.50
$8.33
AVG Volume (30 Days)
1.4M
2.6M
Earning Date
05-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,244,857,000.00
$230,981,000.00
Revenue This Year
$9.00
$1,115.92
Revenue Next Year
$6.93
$81.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.33
$1.26
52 Week High
$13.43
$5.47

Technical Indicators

Market Signals
Indicator
AHCO
PGEN
Relative Strength Index (RSI) 33.66 53.59
Support Level $10.80 $4.02
Resistance Level $13.15 $4.40
Average True Range (ATR) 0.54 0.20
MACD -0.28 -0.01
Stochastic Oscillator 2.26 51.55

Price Performance

Historical Comparison
AHCO
PGEN

About AHCO AdaptHealth Corp.

AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: